These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 10762457)

  • 1. Chlamydia pneumoniae in atherosclerosis.
    Saikku P
    J Intern Med; 2000 Mar; 247(3):391-6. PubMed ID: 10762457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chlamydia pneumoniae and atherosclerosis].
    Andreasen JJ
    Ugeskr Laeger; 1997 Sep; 159(37):5503-7. PubMed ID: 9312918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chlamydial heat-shock protein-60 antibody and correlation with Chlamydia pneumoniae in atherosclerotic plaques.
    Fong IW; Chiu B; Viira E; Tucker W; Wood H; Peeling RW
    J Infect Dis; 2002 Nov; 186(10):1469-73. PubMed ID: 12404163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chlamydia pneumoniae and lipoprotein(a): the right combination for atherosclerosis?
    Cassone A
    Eur Heart J; 2000 Apr; 21(8):599-600. PubMed ID: 10731393
    [No Abstract]   [Full Text] [Related]  

  • 5. [Chlamydia pneumoniae as a causative agent in atherosclerosis].
    van Deventer SJ
    Ned Tijdschr Geneeskd; 1999 Feb; 143(6):288-90. PubMed ID: 10221082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Arteriosclerosis caused by infection? A possible link between Chlamydia pneumoniae and atherosclerosis].
    Persson K; Boman J
    Lakartidningen; 1998 May; 95(20):2334-6, 2339-40. PubMed ID: 9630800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Atherosclerosis and Chlamydia pneumoniae].
    Larsen MM; Mørn B; Andersen PL; Østergaard LJ
    Ugeskr Laeger; 2002 Dec; 164(50):5920-4. PubMed ID: 12553110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Background and current knowledge of Chlamydia pneumoniae and atherosclerosis.
    Grayston JT
    J Infect Dis; 2000 Jun; 181 Suppl 3():S402-10. PubMed ID: 10839724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The studying of Chlamydia pneumoniae in atherosclerosis].
    Sumarokov AB; Pankratova VN; Liakishev AA; Avdeeva IIu
    Klin Med (Mosk); 1999; 77(10):4-7. PubMed ID: 10635643
    [No Abstract]   [Full Text] [Related]  

  • 10. Presence of Chlamydia pneumoniae in patients with and without atherosclerosis.
    Podsiadły E; Przyłuski J; Kwiatkowski A; Kruk M; Wszoła M; Nosek R; Rowiński W; Ruzyłło W; Tylewska-Wierzbanowska S
    Eur J Clin Microbiol Infect Dis; 2005 Aug; 24(8):507-13. PubMed ID: 16133407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of future intervention studies for Chlamydia pneumoniae in atherosclerosis.
    Grayston JT
    Am Heart J; 1999 Nov; 138(5 Pt 2):S556-7. PubMed ID: 10539875
    [No Abstract]   [Full Text] [Related]  

  • 12. [Infection hypothesis for the pathogenesis of atherosclerosis--caused by Chlamydia pneumoniae?].
    Durkalec J; Hasik J
    Przegl Lek; 1999; 56(4):299-301. PubMed ID: 10494168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of Chlamydia pneumoniae infection to severity of human coronary atherosclerosis.
    Ericson K; Saldeen TG; Lindquist O; Pâhlson C; Mehta JL
    Circulation; 2000 Jun; 101(22):2568-71. PubMed ID: 10840006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infections, immunity, and atherosclerosis: associations of antibodies to Chlamydia pneumoniae, Helicobacter pylori, and cytomegalovirus with immune reactions to heat-shock protein 60 and carotid or femoral atherosclerosis.
    Mayr M; Kiechl S; Willeit J; Wick G; Xu Q
    Circulation; 2000 Aug; 102(8):833-9. PubMed ID: 10952949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chlamydia pneumoniae, strain TWAR and atherosclerosis.
    Grayston JT; Kuo CC; Campbell LA; Benditt EP
    Eur Heart J; 1993 Dec; 14 Suppl K():66-71. PubMed ID: 8131792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroepidemiological evidence for an association between Chlamydia pneumoniae and atherosclerosis.
    Orfila JJ
    Atherosclerosis; 1998 Oct; 140 Suppl 1():S11-5. PubMed ID: 9859919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chlamydia pneumoniae and atherosclerosis -- what we know and what we don't.
    Ngeh J; Anand V; Gupta S
    Clin Microbiol Infect; 2002 Jan; 8(1):2-13. PubMed ID: 11906495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is infection with Chlamydia pneumoniae a causative agent in atherosclerosis?
    Kuo C; Campbell LA
    Mol Med Today; 1998 Oct; 4(10):426-30. PubMed ID: 9793930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mediators of arterial inflammation: a role for microbial products?
    Kol A; Libby P
    Am Heart J; 1999 Nov; 138(5 Pt 2):S450-2. PubMed ID: 10539846
    [No Abstract]   [Full Text] [Related]  

  • 20. Chlamydia pneumoniae and atherosclerosis.
    Hoymans VY; Bosmans JM; Ieven M; Vrints CJ
    Acta Chir Belg; 2002 Oct; 102(5):317-22. PubMed ID: 12471763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.